|
Apr 11
|
Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
|
|
Apr 8
|
High Growth Tech Stocks In The US To Watch April 2025
|
|
Apr 7
|
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
|
|
Apr 4
|
Insider-Favored Growth Companies Including Organogenesis Holdings And Two More
|
|
Jan 16
|
Organogenesis Holdings Leads These 3 US Penny Stocks
|
|
Oct 1
|
Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers
|
|
Sep 4
|
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
|
|
Jul 20
|
Organogenesis Holdings Inc. (ORGO): Is It Among the Best NASDAQ Penny Stocks to Invest In Now?
|
|
Jun 8
|
With 38% ownership, Organogenesis Holdings Inc. (NASDAQ:ORGO) insiders have a lot riding on the company's future
|
|
May 12
|
Organogenesis Holdings First Quarter 2024 Earnings: Beats Expectations
|
|
May 10
|
Organogenesis Holdings Inc. Reports First Quarter 2024 Results: A Close Look at Financial ...
|
|
May 10
|
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Q1 2024 Organogenesis Holdings Inc Earnings Call
|
|
May 10
|
Organogenesis (ORGO) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
|
|
May 2
|
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis
|
|
Apr 16
|
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
|
|
Apr 3
|
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
|
|
Feb 8
|
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
|
|
Jan 15
|
Are You Looking for a Top Momentum Pick? Why Organogenesis (ORGO) is a Great Choice
|